← Signal Board

Supernus Pharmaceuticals financial statements

슈퍼누스 파머슈티컬스NASDAQ:SUPN · Nasdaq · Healthcare · sector #17
$43.05+0.51%
2026-10-07 close

Supernus Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $662M. 2024 operating profit was $82M.

Reported results

Supernus Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy